APO Research
Talk to an analyst

APO RESEARCH · REPORT

SARS-CoV-2 IgG (RBD) ELISA

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global SARS-CoV-2 IgG (RBD) ELISA Industry Growth and Trends Forecast to 2032

29 December 2025103 pages

Choose your research edition.

Industry ResearchSARS-CoV-2 IgG (RBD) ELISA Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal SARS-CoV-2 IgG (RBD) ELISA Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal SARS-CoV-2 IgG (RBD) ELISA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SARS-CoV-2 IgG (RBD) ELISA Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal SARS-CoV-2 IgG (RBD) ELISA Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global SARS-CoV-2 IgG (RBD) ELISA market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for SARS-CoV-2 IgG (RBD) ELISA is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for SARS-CoV-2 IgG (RBD) ELISA is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SARS-CoV-2 IgG (RBD) ELISA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the SARS-CoV-2 IgG (RBD) ELISA market include ALPCO, BD Biosciences, BioMérieux, Bio-Rad Laboratories, Enzo Life Sciences, LG, LOEWE Biochemica, Ortho Clinical Diagnostics and R&D Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global SARS-CoV-2 IgG (RBD) ELISA market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The SARS-CoV-2 IgG (RBD) ELISA market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global SARS-CoV-2 IgG (RBD) ELISA market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to SARS-CoV-2 IgG (RBD) ELISA.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global SARS-CoV-2 IgG (RBD) ELISA market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

SARS-CoV-2 IgG (RBD) ELISA Market by Company

ALPCO

BD Biosciences

BioMérieux

Bio-Rad Laboratories

Enzo Life Sciences

LG

LOEWE Biochemica

Ortho Clinical Diagnostics

R&D Systems

Shenzhen YHLO Biotech

ZEUS Scientific

Thermo Fisher Scientific

SARS-CoV-2 IgG (RBD) ELISA Segment by Type

ELISA Sets

ELISA Kits

SARS-CoV-2 IgG (RBD) ELISA Segment by Application

Hospital

Clinic

Disease control and prevention system

SARS-CoV-2 IgG (RBD) ELISA Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SARS-CoV-2 IgG (RBD) ELISA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SARS-CoV-2 IgG (RBD) ELISA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SARS-CoV-2 IgG (RBD) ELISA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of SARS-CoV-2 IgG (RBD) ELISA companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2021-2026) & (US$ Million) Table 3. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2021-2026) Table 4. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2027-2032) & (US$ Million) Table 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2027-2032) Table 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026) & (US$ Million) Table 8. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Type (2021-2026) Table 9. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Share Forecasted by Type (2027-2032) Table 11. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026) & (US$ Million) Table 23. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Application (2021-2026) Table 24. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Share Forecasted by Application (2027-2032) Table 26. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. SARS-CoV-2 IgG (RBD) ELISA Industry Trends Table 37. SARS-CoV-2 IgG (RBD) ELISA Industry Drivers Table 38. SARS-CoV-2 IgG (RBD) ELISA Industry Opportunities and Challenges Table 39. SARS-CoV-2 IgG (RBD) ELISA Industry Restraints Table 40. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (US$ Million) & (2021-2026) Table 41. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Company (2021-2026) Table 42. Global SARS-CoV-2 IgG (RBD) ELISA Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global SARS-CoV-2 IgG (RBD) ELISA Key Company Headquarters & Area Served Table 44. Global SARS-CoV-2 IgG (RBD) ELISA Company, Product Type & Application Table 45. Global SARS-CoV-2 IgG (RBD) ELISA Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global SARS-CoV-2 IgG (RBD) ELISA by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. ALPCO Company Information Table 49. ALPCO Business Overview Table 50. ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 52. ALPCO Recent Development Table 53. BD Biosciences Company Information Table 54. BD Biosciences Business Overview Table 55. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 57. BD Biosciences Recent Development Table 58. BioMérieux Company Information Table 59. BioMérieux Business Overview Table 60. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 62. BioMérieux Recent Development Table 63. Bio-Rad Laboratories Company Information Table 64. Bio-Rad Laboratories Business Overview Table 65. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 67. Bio-Rad Laboratories Recent Development Table 68. Enzo Life Sciences Company Information Table 69. Enzo Life Sciences Business Overview Table 70. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 72. Enzo Life Sciences Recent Development Table 73. LG Company Information Table 74. LG Business Overview Table 75. LG SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. LG SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 77. LG Recent Development Table 78. LOEWE Biochemica Company Information Table 79. LOEWE Biochemica Business Overview Table 80. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 82. LOEWE Biochemica Recent Development Table 83. Ortho Clinical Diagnostics Company Information Table 84. Ortho Clinical Diagnostics Business Overview Table 85. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 87. Ortho Clinical Diagnostics Recent Development Table 88. R&D Systems Company Information Table 89. R&D Systems Business Overview Table 90. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 92. R&D Systems Recent Development Table 93. Shenzhen YHLO Biotech Company Information Table 94. Shenzhen YHLO Biotech Business Overview Table 95. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 97. Shenzhen YHLO Biotech Recent Development Table 98. ZEUS Scientific Company Information Table 99. ZEUS Scientific Business Overview Table 100. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 102. ZEUS Scientific Recent Development Table 103. Thermo Fisher Scientific Company Information Table 104. Thermo Fisher Scientific Business Overview Table 105. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 107. Thermo Fisher Scientific Recent Development Table 108. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) & (US$ Million) Table 110. North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2026) Table 111. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America SARS-CoV-2 IgG (RBD) ELISA Market Share Forecast by Country (2027-2032) Table 113. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2026) Table 116. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2026) Table 121. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Share Forecast by Country (2027-2032) Table 123. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2026) Table 126. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2026) Table 131. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. SARS-CoV-2 IgG (RBD) ELISA Product Image Figure 3. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region: 2025 VS 2032 Figure 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2021-2032) Figure 7. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. ELISA Sets Image Figure 13. Global ELISA Sets Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. ELISA Kits Image Figure 15. Global ELISA Kits Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Type 2025 VS 2032 Figure 18. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Type (2021-2032) Figure 19. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Type (2021-2032) Figure 21. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Disease control and prevention system Image Figure 28. Global Disease control and prevention system Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Application 2025 VS 2032 Figure 31. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Application (2021-2032) Figure 32. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Application (2021-2032) Figure 34. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 SARS-CoV-2 IgG (RBD) ELISA Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 41. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 44. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 47. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 50. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA Sets
  • ELISA Kits
Applications
  • Hospital
  • Clinic
  • Disease control and prevention system
Companies covered
  • ALPCO
  • BD Biosciences
  • BioMérieux
  • Bio-Rad Laboratories
  • Enzo Life Sciences
  • LG
  • LOEWE Biochemica
  • Ortho Clinical Diagnostics
  • R&D Systems
  • Shenzhen YHLO Biotech
  • ZEUS Scientific
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2021-2032)
  5. 1.4.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2021-2026)
  6. 1.4.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2027-2032)
  7. 1.5 Key Regions SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032)
  8. 1.5.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (2021-2032)
2 SARS-CoV-2 IgG (RBD) ELISA Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 ELISA Sets
  3. 2.1.2 ELISA Kits
  4. 2.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
  5. 2.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Regions
  9. 2.3.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Type (2021-2026)
3 SARS-CoV-2 IgG (RBD) ELISA Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Disease control and prevention system
  5. 3.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
  6. 3.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Regions
  10. 3.3.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 SARS-CoV-2 IgG (RBD) ELISA Industry Trends
  2. 4.2 SARS-CoV-2 IgG (RBD) ELISA Industry Drivers
  3. 4.3 SARS-CoV-2 IgG (RBD) ELISA Industry Opportunities and Challenges
  4. 4.4 SARS-CoV-2 IgG (RBD) ELISA Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by SARS-CoV-2 IgG (RBD) ELISA Revenue (2021-2026)
  2. 5.2 Global SARS-CoV-2 IgG (RBD) ELISA Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global SARS-CoV-2 IgG (RBD) ELISA Key Company Headquarters & Area Served
  4. 5.4 Global SARS-CoV-2 IgG (RBD) ELISA Company, Product Type & Application
  5. 5.5 Global SARS-CoV-2 IgG (RBD) ELISA Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global SARS-CoV-2 IgG (RBD) ELISA Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 SARS-CoV-2 IgG (RBD) ELISA Players Market Share by Revenue in 2025
  9. 5.6.3 2025 SARS-CoV-2 IgG (RBD) ELISA Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 ALPCO
  2. 6.1.1 ALPCO Company Information
  3. 6.1.2 ALPCO Business Overview
  4. 6.1.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  6. 6.1.5 ALPCO Recent Developments
  7. 6.2 BD Biosciences
  8. 6.2.1 BD Biosciences Company Information
  9. 6.2.2 BD Biosciences Business Overview
  10. 6.2.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  12. 6.2.5 BD Biosciences Recent Developments
  13. 6.3 BioMérieux
  14. 6.3.1 BioMérieux Company Information
  15. 6.3.2 BioMérieux Business Overview
  16. 6.3.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  18. 6.3.5 BioMérieux Recent Developments
  19. 6.4 Bio-Rad Laboratories
  20. 6.4.1 Bio-Rad Laboratories Company Information
  21. 6.4.2 Bio-Rad Laboratories Business Overview
  22. 6.4.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  24. 6.4.5 Bio-Rad Laboratories Recent Developments
  25. 6.5 Enzo Life Sciences
  26. 6.5.1 Enzo Life Sciences Company Information
  27. 6.5.2 Enzo Life Sciences Business Overview
  28. 6.5.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  30. 6.5.5 Enzo Life Sciences Recent Developments
  31. 6.6 LG
  32. 6.6.1 LG Company Information
  33. 6.6.2 LG Business Overview
  34. 6.6.3 LG SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 LG SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  36. 6.6.5 LG Recent Developments
  37. 6.7 LOEWE Biochemica
  38. 6.7.1 LOEWE Biochemica Company Information
  39. 6.7.2 LOEWE Biochemica Business Overview
  40. 6.7.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  42. 6.7.5 LOEWE Biochemica Recent Developments
  43. 6.8 Ortho Clinical Diagnostics
  44. 6.8.1 Ortho Clinical Diagnostics Company Information
  45. 6.8.2 Ortho Clinical Diagnostics Business Overview
  46. 6.8.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  48. 6.8.5 Ortho Clinical Diagnostics Recent Developments
  49. 6.9 R&D Systems
  50. 6.9.1 R&D Systems Company Information
  51. 6.9.2 R&D Systems Business Overview
  52. 6.9.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  54. 6.9.5 R&D Systems Recent Developments
  55. 6.10 Shenzhen YHLO Biotech
  56. 6.10.1 Shenzhen YHLO Biotech Company Information
  57. 6.10.2 Shenzhen YHLO Biotech Business Overview
  58. 6.10.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  60. 6.10.5 Shenzhen YHLO Biotech Recent Developments
  61. 6.11 ZEUS Scientific
  62. 6.11.1 ZEUS Scientific Company Information
  63. 6.11.2 ZEUS Scientific Business Overview
  64. 6.11.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  66. 6.11.5 ZEUS Scientific Recent Developments
  67. 6.12 Thermo Fisher Scientific
  68. 6.12.1 Thermo Fisher Scientific Company Information
  69. 6.12.2 Thermo Fisher Scientific Business Overview
  70. 6.12.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  72. 6.12.5 Thermo Fisher Scientific Recent Developments
7 North America
  1. 7.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  3. 7.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  3. 8.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  3. 10.3 South America SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst